Vitality Watch

Dossier pubmed preclinical 03-oct-2026
Animal model, organoid, or cell-culture result — not yet human

Cyclooxygenase-1-sensitive oxidative responses to thromboxane-prostanoid receptor activation during vascular aging and experimental menopause.

Key claim: In senescence-accelerated female mice, estrogen status shapes thromboxane-prostanoid receptor–mediated aortic contraction via nitric oxide restraint, and TP activation drives a COX-1-sensitive oxidative response that remains elevated after ovariectomy.

Abstract

Vascular aging and menopause increase cardiovascular risk in females, but the interplay among cyclooxygenase-1 (COX-1), thromboxane-prostanoid (TP) receptor signaling, nitric oxide (NO), and oxidative stress in the aging female vasculature remains unclear. We examined TP receptor-mediated responses in thoracic aortas from senescence-accelerated mouse-resistant 1 (SAMR1) and senescence-accelerated mouse-prone 8 (SAMP8) mice subjected to sham surgery (Sham), ovariectomy (Ovx), or ovariectomy followed by estradiol replacement (OvE). Aortic rings were exposed to U46619 (10-3x10M) before and after incubation with the COX-1 inhibitor SC-560 (10M), the nitric oxide synthase (NOS) inhibitor N-nitro-L‑arginine methyl ester (L-NAME, 10M), or both. Superoxide production was assessed by dihydroethidium (DHE) fluorescence after exposure to U46619 (10M), with or without SC-560, and COX-1 expression was evaluated. U46619 induced concentration-dependent contractions in both strains. In Sham and OvE mice, L-NAME enhanced TP receptor-mediated contraction, whereas SC-560 exerted little effect. This L-NAME effect was blunted after ovariectomy; however, combined NOS and COX-1 inhibition significantly increased contractile responses. Ovariectomized SAMP8 mice showed the greatest TP receptor-mediated contractions, whereas estradiol replacement reduced contractile responses and restored NO-dependent modulation. U46619 increased vascular DHE fluorescence in all groups, and SC-560 attenuated this response. However, after ovariectomy, fluorescence remained significantly above basal levels despite COX-1 inhibition. COX-1 gene expression showed no major strain- or hormone-dependent differences. These findings indicate that estrogen status shapes TP receptor-mediated vascular responses by modulating NO-dependent restraint and reveal a COX-1-sensitive component of TP receptor-associated oxidative signaling in the absence of major changes in vascular COX-1 expression.

Why this matters

In senescence-accelerated female mice, estrogen status shapes thromboxane-prostanoid receptor–mediated aortic contraction via nitric oxide restraint, and TP activation drives a COX-1-sensitive oxidative response that remains elevated after ovariectomy.

Source

Link

Briefing card

Cyclooxygenase-1-sensitive oxidative responses to thromboxane-prostanoid receptor activation during vascular aging and experimental menopause.
Stage: preclinical · pubmed · 03-oct-2026

In senescence-accelerated female mice, estrogen status shapes thromboxane-prostanoid receptor–mediated aortic contraction via nitric oxide restraint, and TP activation drives a COX-1-sensitive oxidative response that remains elevated after ovariectomy.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: doi:10.1016/j.bcp.2026.118521

build build 880 · 2bcef25 · 2026-11-18